WiseGuyReports has announced the addition of a new intelligence report, titled “Drug Discovery Technologies”.
The drug discovery industry has witnessed growth in the past few years owing to progress in biochemical, translational and molecular studies in biomedical research. These tools are commercially employed in the development of novel and efficient drug candidates. The booming healthcare sector and increased government funding has aided significant growth in the biomedical industry. The delineation of mechanistic details and the underlying mechanisms of drug target interaction have paved the way for more efficient and accurate therapies. The biopharmaceutical industry and various research institutes are conducting exhaustive research in the field of drug discovery.
The expanding field of drug discovery and development is allowing researchers to focus on discovering important lead compounds for various forms of cancer and other diseases. Globally, biopharmaceutical companies and research institutes are exploring several molecular and biochemical aspects to develop mechanistic approaches for drug discovery. Various tools such as high-throughput screening, proteomics and genomic tools, including quantitative reverse transcription polymerase chain reaction (qRT-PCR), next generation sequencing (NGS) and many others, are being widely used for cellular analysis.
In the last decade, the drug discovery tools market has witnessed increased usage in the biomedical industry. Applications are proteomics, next-generation sequencing and high-throughput screening tools that target cancers and other diseases, including autoimmune diseases. A rise in R&D, the growing incidences of various life-threatening diseases and the increasing global population are all market drivers. Companies are focusing on enhancing biomedical research and advancement of superior technologies in order to provide better quality of treatment and therapies. One industry source described the current drug discovery process as driven by the computational method using bioinformatic tools, followed by drug innovation in the pharmaceutical industry, plant-derived drug discoveries and, lastly, through the translation of molecules.
Collaborative efforts of researchers and the pharmaceutical industry are establishing various promising future drug candidates. Drug discovery find applications in cardiovascular, neurological, cancer and other disease areas. Some key players in this space include Thermo Fisher Scientific, Shimadzu Corp., Illumina Inc. and Bio-Rad Laboratories Ltd. Major end users of these products are research centers, academic institutions, government and private laboratories, as well as pharmaceutical, biotechnology companies and contract research organizations.
North America held the biggest share of the drug discovery tools market during the reporting period. This region is expected to continue increasing at an estimated compound annual growth rate (CAGR) of 10.9% through 2022. An aggressive research environment and government funding for various projects related to drug discovery is helping to boost the sector
In the emerging regions, China and India, in particular, remain attractive markets for healthcare. Asian countries are attracting various pharmaceutical and biotechnological companies due to their heterogeneous patient population pool. In addition, China is now a major research center with a large number of collaborative research efforts throughout the country. Countries comprising the emerging market is expected to see the value of its drug discovery sector rise at a CAGR of 8.6% to reach $29.2Bn by 2022.”
Request Sample Report at https://www.wiseguyreports.com/sample-request/2841671-drug-discovery-technologies
In recent years, the drug discovery market has seen remarkable discoveries and rapid progress. This report focuses on the global market of drug discovery tools and provides an updated review to include basic design and its applications in various disease areas. The drug discovery tools include high-throughput screening, bioanalytical tools, proteomics, genomics, bioinformatics and few others, like metabolomics, combinatorial chemistry, nanotechnology and system biology. These tools are further classified into subcategories for the purpose of this report. The five main application areas described in this report concern different cancer types, cardiovascular diseases, immunological diseases, neurological diseases and others which includes metabolic, endocrinology and genetic diseases.
The report also covers market by end user for drug discovery tools: biopharmaceutical companies, research, academia and others, including contract research organizations.
This Research report is global in scope and includes analysis of the various regulatory environments, new products and advancements, market projections and market share. Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the drug discovery tools market. The geographical regions covered are the U.S., Europe and the emerging markets of India, China, Japan, South Korea, Taiwan, Africa, Australia, New Zealand, Canada, among others.
Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., Illumina Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., and Merck KGaA (including EMD Millipore and Sigma Aldrich).
View Detailed Report at https://www.wiseguyreports.com/reports/2841671-drug-discovery-technologies
– 60 data tables and 23 additional tables.
– An overview of the global markets for drug discovery technologies.
– Analyses of global market trends with data from 2015, 2016, and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
– A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environment, including new and potential venues for novel technologies and approaches.
– Descriptions of various products, such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.
– Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies across different segments of the industry.
– Comprehensive company profiles of major players in the market including Agilent Technologies Inc., Ametek Inc., Bayer Technology Services GMBH, Bruker Corp., Compugen Ltd. and GE Healthcare Lifesciences.
AGILENT TECHNOLOGIES INC
APPLIED MATHS NV
Bayer Technology Services GmbH
BIO-RAD LABORATORIES LTD
BIOCRATES LIFE SCIENCES AG
BIOMAX INFORMATICS AG
BIOTEK INSTRUMENTS INC.
CARL ZEISS MICROIMAGING GMBH
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CODEX BIOSOLUTIONS INC.
GE HEALTHCARE LIFESCIENCES
GENEVA BIOINFORMATICS SA
HAMILTON ROBOTICS INC.
HITACHI HIGH-TECHNOLOGIES CORP.
HUMAN METABOLOME TECHNOLOGIES INC.
INTEGRATED DNA TECHNOLOGIES INC.
JEOL USA INC.
LONZA GROUP AG
ROCHE HOLDING LTD.
THERMO FISHER SCIENTIFIC INC.
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Technology Type
Chapter 5 Market Breakdown by End User
Chapter 6 Market Breakdown by Disease
Chapter 7 Market Breakdown by Region
Chapter 8 Industry Structure
Chapter 9 Patent Review/New Developments/Regulatory Aspects
Chapter 10 Analysis of Market Opportunities
Chapter 11 Company Profiles
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)